MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • MDS Virtual Congress 2021

    Characterising the incidence of comorbidities, hospitalisations, and death in patients diagnosed with Huntington’s disease: A cohort study of linked Swedish National Registries (2002-2019)

    H. Furby, S. Moore, A. Nordstroem, R. Houghton, D. Lambrelli, S. Graham, P. Svenningsson, A. Petersen (Welwyn Garden City, United Kingdom)

    Objective: To investigate comorbidities, hospitalizations, and mortality in patients newly diagnosed with Huntington’s disease using data extracted from three linked Swedish national health registries from…
  • MDS Virtual Congress 2021

    A case of Bainbridge-Ropers syndrome in a child.

    S. Kopishinskaia, A. Sitnikova, E. Parinova (Nizhny Novgorod, Russian Federation)

    Objective: This study describe the clinical case of Bainbridge-Ropers syndrome caused by the ASXL3 gene mutation. Background: Bainbridge-Ropers syndrome is an autosomal dominant disorder typically…
  • MDS Virtual Congress 2021

    Diabetes Mellitus in Huntington’s disease. The Argentinean perspective

    N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: to compare the prevalence of diabetes mellitus (DM) in a self-reported series of local Huntington disease (HD) participants in the ENROLL-HD registry with the…
  • MDS Virtual Congress 2021

    Evaluation of Health-Related Quality of Life for Individuals with Huntington’s Disease and Care Partners in Canada

    N. Budd, T. Mestre, E. Shaw, M. Mayer, P. Ekwaru, S. Mcmullen, E. Graves, J. Wu, B. Maturi, T. Cowling (Mississauga, Canada)

    Objective: To evaluate the impact of Huntington’s disease (HD) on health-related quality of life (HRQoL) for individuals with HD and care partners in Canada. Background:…
  • MDS Virtual Congress 2020

    Huntington’s disease in Egypt; A big challenge for a mysterious disease

    S. El-Jaafary, A. Sabbah, H. Amer (Cairo, Egypt)

    Objective: To identify the challenges of managing Huntington’s disease in Egypt in order to overcome them. Background: Huntington’s disease (HD) is considered a rare disease…
  • MDS Virtual Congress 2020

    Parkinsonism, delayed chorea and dystonia caused by extrapontine myelinolysis

    N.A Gandarilla Martínez, H.R Martínez Hernández (Mexico City, Mexico)

    Objective: To describe two case reports of patients with movement disorders due to extrapontine myelinolysis. Background: Central Pontine Myelinolysis (CPM) and Extra pontine myelinolysis (EPM)…
  • MDS Virtual Congress 2020

    Association between the number of CAG repetitions and cognitive performance in Huntington’s disease in patients of the National Institute of Neurology and Neurosurgery “MVS”

    D. Gasca-Saldaña, A. Vega-Rosas, G. Palma-Cordero, O. Castellanos-Maya (CDMX, Mexico)

    Objective: To establish the relationship between the number of CAG repetitions and the total Montreal Cognitive Assessment (MoCA) scores in patients with Huntington disease (HD).…
  • MDS Virtual Congress 2020

    Mcleod syndrome: Systematic review with meta-analysis

    A. Rochel Pérez, O. Cuevas Koh, K. Santos Zaldivar, R. Leal Ortega, R. Janssen-Aguilar, N. Mendez Dominguez (Mérida, Mexico)

    Objective: Analyze, review and describe the pathognomonic or characteristic signs and symptoms of Mcleod syndrome. Background: Mcleod syndrome is caused due to a mutation of…
  • MDS Virtual Congress 2020

    Cardiovascular risk factors in a pre-manifest and manifest population of Huntington’s disease

    E. Gatto, N. Gonzalez Rojas, M. Cesarini, J. Etcheverry, G. Da Prat (Buenos Aires, Argentina)

    Objective: To identify cardiovascular risk factors in a self-reported series of local Huntington's disease participants in the ENROLL-HD registry Background: Population studies have contributed to…
  • MDS Virtual Congress 2020

    Measure of Social Relation in Huntington’s Disease: The Relationship Self-Questionnaire (RSQ)

    J. Hamet Bagnou, R. Massart, K. Hernandez, R. Fliss, M. Lunven, E. Audureau, A.C Bachoud-Levi (Creteil, France)

    Objective: Development and validation of the Relationship Self-Questionnaire (RSQ), specific to Huntington’s disease (HD), which aims tomeasurepatients self-perceived quality of their relationships (RS). Background: In…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley